Your browser doesn't support javascript.
loading
Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
López-Causapé, Carla; de Dios-Caballero, Juan; Cobo, Marta; Escribano, Amparo; Asensio, Óscar; Oliver, Antonio; Del Campo, Rosa; Cantón, Rafael; Solé, Amparó; Cortell, Isidoro; Asensio, Oscar; García, Gloria; Martínez, María Teresa; Cols, María; Salcedo, Antonio; Vázquez, Carlos; Baranda, Félix; Girón, Rosa; Quintana, Esther; Delgado, Isabel; de Miguel, María Ángeles; García, Marta; Oliva, Concepción; Prados, María Concepción; Barrio, María Isabel; Pastor, María Dolores; Olveira, Casilda; de Gracia, Javier; Álvarez, Antonio; Escribano, Amparo; Castillo, Silvia; Figuerola, Joan; Togores, Bernat; Oliver, Antonio; López, Carla; de Dios Caballero, Juan; Tato, Marta; Máiz, Luis; Suárez, Lucrecia; Cantón, Rafael.
Afiliação
  • López-Causapé C; Servicio de Microbiología and Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain; Red Española de Investigación en Patología Infecciosa, Instituto de Salud Carlos III, Madrid, Spain.
  • de Dios-Caballero J; Red Española de Investigación en Patología Infecciosa, Instituto de Salud Carlos III, Madrid, Spain; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
  • Cobo M; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
  • Escribano A; Unidad de Neumología Pediátrica y Fibrosis Quística, Servicio de Pediatría, Hospital Clínico Universitario and Universidad de Valencia, Valencia, Spain.
  • Asensio Ó; Unidad de Neumología y Alergia Pediátrica, Hospital Universitario de Sabadell, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain.
  • Oliver A; Servicio de Microbiología and Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears, Palma de Mallorca, Spain; Red Española de Investigación en Patología Infecciosa, Instituto de Salud Carlos III, Madrid, Spain.
  • Del Campo R; Red Española de Investigación en Patología Infecciosa, Instituto de Salud Carlos III, Madrid, Spain; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain. Electronic address: rosacampo@yahoo.com.
  • Cantón R; Red Española de Investigación en Patología Infecciosa, Instituto de Salud Carlos III, Madrid, Spain; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
  • Solé A; La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Cortell I; La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Asensio O; Corporació Sanitaria Parc Taulí, Sabadell, Barcelona, Spain.
  • García G; Hospital 12 de Octubre, Madrid, Spain.
  • Martínez MT; Hospital 12 de Octubre, Madrid, Spain.
  • Cols M; Hospital San Joan de Déu, Barcelona, Spain.
  • Salcedo A; Hospital Niño Jesús/Gregorio Marañón, Madrid, Spain.
  • Vázquez C; Cruces University Hospital, Barakaldo, Vizcaya, Spain.
  • Baranda F; Cruces University Hospital, Barakaldo, Vizcaya, Spain.
  • Girón R; Hospital de la Princesa, Madrid, Spain.
  • Quintana E; Virgen del Rocío University Hospital, Seville, Spain.
  • Delgado I; Virgen del Rocío University Hospital, Seville, Spain.
  • de Miguel MÁ; Central University Hospital of Asturias, Oviedo, Asturias, Spain.
  • García M; Central University Hospital of Asturias, Oviedo, Asturias, Spain.
  • Oliva C; Nuestra Señora de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain.
  • Prados MC; La Paz University Hospital, Madrid, Spain.
  • Barrio MI; La Paz University Hospital, Madrid, Spain.
  • Pastor MD; Virgen de la Arrixaca University Hospital Clinic, Murcia, Spain.
  • Olveira C; Regional University Hospital of Malaga, Malaga, Spain.
  • de Gracia J; Vall d'Hebrón Hospital, Barcelona, Spain.
  • Álvarez A; Vall d'Hebrón Hospital, Barcelona, Spain.
  • Escribano A; University Hospital Clinic of Valencia, University of Valencia, Valencia, Spain.
  • Castillo S; University Hospital Clinic of Valencia, University of Valencia, Valencia, Spain.
  • Figuerola J; Son Espases University Hospital, Palma de Mallorca, Spain.
  • Togores B; Son Espases University Hospital, Palma de Mallorca, Spain.
  • Oliver A; Son Espases University Hospital, Palma de Mallorca, Spain.
  • López C; Son Espases University Hospital, Palma de Mallorca, Spain.
  • de Dios Caballero J; Ramón y Cajal University Hospital, Madrid, Spain.
  • Tato M; Ramón y Cajal University Hospital, Madrid, Spain.
  • Máiz L; Ramón y Cajal University Hospital, Madrid, Spain.
  • Suárez L; Ramón y Cajal University Hospital, Madrid, Spain.
  • Cantón R; Ramón y Cajal University Hospital, Madrid, Spain.
Int J Antimicrob Agents ; 50(3): 334-341, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28735882
ABSTRACT
The first Spanish multi-centre study on the microbiology of cystic fibrosis (CF) was conducted from 2013 to 2014. The study involved 24 CF units from 17 hospitals, and recruited 341 patients. The aim of this study was to characterise Pseudomonas aeruginosa isolates, 79 of which were recovered from 75 (22%) patients. The study determined the population structure, antibiotic susceptibility profile and genetic background of the strains. Fifty-five percent of the isolates were multi-drug-resistant, and 16% were extensively-drug-resistant. Defective mutS and mutL genes were observed in mutator isolates (15.2%). Considerable genetic diversity was observed by pulsed-field gel electrophoresis (70 patterns) and multi-locus sequence typing (72 sequence types). International epidemic clones were not detected. Fifty-one new and 14 previously described array tube (AT) genotypes were detected by AT technology. This study found a genetically unrelated and highly diverse CF P. aeruginosa population in Spain, not represented by the epidemic clones widely distributed across Europe, with multiple combinations of virulence factors and high antimicrobial resistance rates (except for colistin).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Variação Genética / Fibrose Cística / Farmacorresistência Bacteriana Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Antimicrob Agents Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Variação Genética / Fibrose Cística / Farmacorresistência Bacteriana Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Antimicrob Agents Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha